for the Cornea Donor Study Investigator Group Purpose: To assess the relationship between donor and recipient factors and corneal allograft rejection in eyes that underwent penetrating keratoplasty in the Cornea Donor Study.
T he Cornea Donor Study (CDS) was initiated for the principal purpose of determining the effect of donor age on the outcome of penetrating keratoplasty (PK) in moderate-risk recipients. The primary study led the investigators to conclude that donor age does not influence the 5-year success of corneal transplantation when corneas from donors up to 75 years of age are screened for adequate endothelial cell density (ECD). 1 The prospective nature of the study and the consistent postoperative follow-up of the CDS subjects provide a unique opportunity to evaluate the influence of other donor and recipient factors, which may impact the outcome of PK. We used the CDS data set to assess the effect of donor and recipient factors on corneal allograft rejection.
MATERIALS AND METHODS

Study Protocol
Earlier publications 1-3 provide a detailed description of the CDS study protocol, including the Specular Microscopy Ancillary Study. Institutional review boards at each participating site approved the study protocol, and written consent was obtained from each subject. Subjects were eligible for the study if they were 40 to 80 years of age and had corneal disease producing endothelial cell dysfunction (primarily Fuchs dystrophy and pseudophakic corneal edema). Surgeons reported the primary indication for transplant. Donors were aged 10 to 75 years with an ECD of 2300 to 3300 cells per square millimeter. Surgeons and subjects were masked to age and ECD of the donors. Corneal tissue assignment was made without regard to age or any other subject characteristics. Preoperative care, surgical technique, and postoperative care (including prescription of medications) were provided according to the customary routine of each surgeon. The number and timing of visits for the first 6 months after PK were left to the discretion of each investigator. Thereafter, the minimum follow-up visit schedule included visits at 6 months, 1 year, and then annually for 5 years.
Graft clarity was assessed, and signs of graft rejection, if present, were recorded at each follow-up examination. Graft failure was defined as a regraft or loss of central graft clarity sufficient to compromise vision for a minimum of 3 consecutive months. Graft rejection was classified as definite when an endothelial rejection line was present in a graft that was previously clear and as probable when there was inflammation (stromal infiltrate, keratic precipitates, cells in the anterior chamber, or ciliary injection) without an endothelial rejection line in a graft that was previously clear. Treatment of graft rejection was left to the discretion of each investigator.
Statistical Methods
The primary outcome for the analyses was the occurrence of probable or definite graft rejection (irreversible or reversible). There were too few definite rejection events for an analysis of these events alone to be meaningful, so definite and probable events were combined. The lack of a standardized protocol for treatment of rejection episodes made it impossible to determine systematically when one rejection episode ended and the eye became at risk for another episode. Therefore, for purposes of this analysis, eyes were classified as to whether they experienced no rejection or experienced at least 1 rejection event. Life table analysis was used to compute the probability of a first rejection event within intervals defined by the study examination schedule (6 months, 1 year, and annually during the 5 years of follow-up). Data were censored at the time of a nonrejection graft failure or at the last visit. Associations of baseline recipient and donor factors with the occurrence of a rejection event were assessed in univariate and multivariate proportional hazards models. Baseline corneal diagnosis and post-transplant lens status were combined into a single variable because these 2 parameters were not independent, as pseudophakic/aphakic corneal edema, by definition, could not be associated with a phakic state. Missing covariates were handled by including missing as a separate category for discrete covariates and adding an indicator for a missing value for continuous covariates. The final multivariate model was obtained through forward selection of covariates (P , 0.05). The large number of statistical comparisons increases the likelihood of a false-positive, and no attempt was made to control the overall type I error probability in these exploratory analyses. The impact of a rejection event on graft failure from all causes was assessed by including the rejection event as a time-dependent variable in a proportional hazards regression model. Proportional hazards assumptions were checked using time-dependent variables with logarithmic transformation of time. No significant de-viation from the proportional hazards assumption was detected for these models. All reported P values are 2 sided. Statistical analyses were conducted using SAS version 9.2 software (SAS Institute, Inc, Cary, NC).
RESULTS
Subject Characteristics
The mean (±SD) age at the time of transplant of the 1090 subjects included in this analysis was 70 ± 9 years; 697 (64%) were female and 1011 (93%) were white and non-Hispanic. Indications for corneal transplantation included Fuchs dystrophy in 676 eyes (62%), pseudophakic/aphakic corneal edema in 369 eyes (34%), and a variety of other causes in 45 eyes (4%).
Rejection Events
During the 5 years of follow-up, 247 subjects (23%) experienced at least 1 rejection event. Eighty subjects (7%) experienced a definite rejection event, and an additional 167 (15%) experienced a probable rejection event. The 5-year predicted probability [± 95% confidence interval (CI)] of a probable or definite rejection was 26% ± 3%. The majority of these events occurred within the first 2 years postoperatively (2-year predicted probability = 17% ± 2%; Fig. 1 ).
Factors Predictive of Rejection Events
Eyes with pseudophakic/aphakic corneal edema (n = 369) were more likely than those with Fuchs dystrophy (n = 676) to experience a rejection event [34% ± 6% vs. 22% ± 4%; hazard ratio (HR) = 1.56; 95% CI, 1.21-2.03; P , 0.001; Fig. 1 ].
In a multivariate analysis, a variable combining preoperative diagnosis and lens status (P , 0.001) and recipient gender (P = 0.01) demonstrated significant associations with a rejection event ( Table 1 ). These relationships remained significant after the model was adjusted for donor age. Among eyes with Fuchs dystrophy, a higher probability of a rejection event was observed in the 153 eyes that were phakic posttransplant compared with the 307 eyes that had their natural lens removed or removed and replaced with an intraocular lens during the surgery (29% vs. 19%; HR = 0.54; 95% CI 0.36 to 0.82; Table 1 ). The probability of rejection in the 216 eyes with Fuchs dystrophy that were pseudophakic or aphakic before transplant surgery was intermediary (23%).
A higher probability of a rejection event was observed among female recipients compared with male recipients (29% vs. 21%; HR = 1.42; 95% CI, 1.08-1.87; Table 1 ) after controlling for the effect of baseline diagnosis and lens status. History of glaucoma, history of vitrectomy, and recipient race were significantly associated with rejection in univariate, but not in multivariate, analysis after controlling for the confounding effect of preoperative diagnosis (pseudophakic or aphakic corneal edema vs. Fuchs dystrophy). Donor age, ABO compatibility, or any other donor factors (Table 2) were not associated with the occurrence of rejection.
Association of Rejection Events and Graft Failure
By 5 years postoperatively, 37% (92 of 247) of the eyes with a rejection event experienced graft failure compared with 5% (43 of 843) of eyes without a rejection event (timedependent HR = 15.03; 95% CI, 10.34-21.83; P , 0.001).
DISCUSSION
Immunologic graft rejection after corneal transplantation is less likely than it is after solid organ transplantation. This is attributable to the naturally avascular corneal anatomy, the immunosuppressive ocular microenvironment, and the phenomenon of anterior chamber-associated immune deviation. The latter produces tolerance, rather than the induction of immunity to antigens introduced into the anterior chamber in experimental animal models. 4, 5 However, in eyes with corneal neovascularization and previous graft rejection, the prognosis for corneal graft survival is reduced and the incidence of rejection is high, similar to that of solid organ transplants.
Histocompatibility antigens are expressed by corneal epithelial, stromal, and endothelial cells. Their density is †Postoperatively, 299 subjects were pseudophakic and 8 subjects were aphakic. ‡Preoperatively, 179 subjects were pseudophakic and 37 subjects were aphakic; postoperatively, 202 subjects were pseudophakic and 14 subjects were aphakic. §Preoperatively, 345 subjects were pseudophakic and 24 subjects were aphakic; postoperatively, 361 subjects were pseudophakic and 8 subjects were aphakic. ¶Includes 45 subjects with a variety of diagnoses: 12 with interstitial keratitis, 7 with posterior polymorphous dystrophy, 6 with perforating corneal injury, and 20 with other causes of endothelial failure. PACE, pseudophakic/aphakic corneal edema. greatest on epithelial cells, and histocompatibility antigen expression is greater on corneas of younger individuals when compared with older individuals. 6 These laboratory data have led to the hypothesis that rejection of corneal tissue from younger donors might be more likely than that from older donors. This hypothesis is supported by the case-control study of Palay et al, 7 who found a greater likelihood of allograft rejection when younger donor tissue is transplanted into adult recipients. Traditionally, eye banks and surgeons tend to match donors and recipients for age. Thus, it is often difficult to study the effects of donor and recipient age independently in any retrospective analysis of corneal graft failure. Many previously published studies have focused on prognostic factors for the success of transplants into high-risk recipients, which represent a minority of corneal grafts, and the results of these studies may not be applicable to low-risk recipients. In contrast, the CDS excluded eyes with ocular surface disease, neovascularization, and previous corneal grafts. Donor tissue was randomly assigned to recipients without regard to age. Thus, the CDS provides an excellent opportunity to study prospectively the impact of donor and recipient age, and other factors, on corneal graft rejection in a moderate-risk population. In addition, the CDS provides an opportunity to further explore the findings of the Collaborative Corneal Transplant Studies (CCTS) that ABO compatibility between donor and recipient is a good prognostic factor for corneal transplant survival. 8, 9 In the current study, we found that the likelihood of rejection events was significantly higher in eyes with pseudophakic or aphakic corneal edema than in those with Fuchs dystrophy. One possible explanation would be that the presence of an intraocular lens causes inflammation, which may, in turn, promote rejection. 10 A curious finding was the fact that among the eyes with Fuchs dystrophy, graft rejection occurred less frequently in eyes that were pseudophakic or aphakic after the transplant surgery compared with those that were phakic. This seems counterintuitive particularly because the rejection rate was higher in eyes with pseudophakic or aphakic corneal edema than in those with Fuchs dystrophy. This may be a chance finding because of the large number of statistical comparisons performed in this exploratory analysis. Alternately, it could reflect the possibility that the eyes that had the lens removed at the time of transplant were treated more intensively or longer with corticosteroids compared with the phakic eyes, and this treatment reduced the rate of rejection. Unfortunately, we did not collect detailed treatment data to be able to address this issue.
We also found that female recipients were more likely to have a rejection event than male recipients. This finding may also be a spurious result of analysis with multiple comparisons. Review of the literature shows conflicting results for the effect of gender. Jonas et al 11 reported that graft rejections were more frequent in men than women, whereas Kuchle et al 12 reported no correlation of gender with rejection episodes. Anshu et al 13 found that female gender was predictive of failure, whereas Bachmann et al 14 reported the opposite. Interestingly, even though women were more likely than men to have a rejection episode in the CCTS, female gender was not predictive of graft failure. We have been unable to reconcile these apparently conflicting findings.
We did not find an association between graft rejection and donor age. Thus, the present study fails to confirm the results of Palay et al, 7 who found a greater likelihood of allograft rejection when younger donor tissue was transplanted into adult recipients using a case-control experimental design. However, donors included in the study by Palay †P value from model fit with continuous factor. ‡Excludes 13 Hispanics, 8 Asian, and 8 other race recipients because groups were too small to analyze separately. §Unknown for 50 subjects. ¶One subject with missing value for bed size. jjSeven subjects with missing value for postoperative intraocular pressure. **Excludes 11 Hispanics, 3 Asian, and 11 other race donors because groups were too small to analyze separately. † †Eighty-eight subjects with missing ABO type. ‡ ‡One hundred thirty-three subjects with missing Rh blood type. § §One hundred seventy-seven subjects with missing ABO/Rh type. et al 7 were younger than 6 years, whereas in CDS, only corneas from donors aged 10 years and older were used. Laboratory investigations have reported a significantly higher histocompatibility antigen expression only in donors younger than 2 years. Thus, failure of the CDS to confirm the greater likelihood of rejection of younger donor tissue may be attributable to the exclusion of very young donors from the CDS. The results of this study also did not confirm the finding of the CCTS that ABO incompatibility reduces corneal transplant survival. 8 This could be explained by the fact that the CCTS conclusion is based on an observation that is attributable to chance, that the sample size of the CDS was too small to demonstrate statistical significance, or that factors operative in the CCTS high-risk population are not the same as those operative in the CDS population, which excluded high-risk recipients.
In summary, the CDS found a substantially higher graft rejection rate in eyes with pseudophakic or aphakic corneal edema compared with those with Fuchs dystrophy. Further studies would be useful to address whether antiinflammatory postoperative treatment affects the rate of graft rejection.
